Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment)

• Autors principals: Nakamura T (Autor), Kubota T (Autor), Iwakaji A (Autor), Imada M (Autor), Kapás M (Autor), Morio Y (Autor)
• Format: Llibre
• Publicat: Dove Medical Press, 2016-01-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Tadakatsu Nakamura,1 Tomoko Kubota,1 Atsushi Iwakaji,1 Masayoshi Imada,1 Margit Kapás,2 Yasunori Morio1 1Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan; 2Developmental Drug Metabolism and Pharmacokinetics, Gedeon Richter Plc, Budapest, Hungary Purpose: Cari...